comparemela.com

Latest Breaking News On - Tiziana life sciences announces - Page 1 : comparemela.com

Media: Neurology Live Coverage

FDA Clears IND to Test Intranasal Foralumab in Alzheimer Disease Aug 15, 2023 Isabella Ciccone, MPH Foralumab, a therapy designed to bind to T. -Today at 07:53 am- MarketScreener

Isabella cicconeRobertl krocGabriele cerroneHowardl weinerTanuja chitnisTiziana life sciencesHarvard medical schoolPartners multiple sclerosis centerTiziana life sciences announcesTest intranasal foralumabTiziana life scienceNeurologic diseasesMass general brigham healthcare systemLife sciences announcesIntranasal foralumabPublished august

Tiziana Life Sciences : Report Of Foreign Private Issuer - Form 6-K

Exhibit 99.1 Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer s Disease to be Presented by Dr. Howard Weiner at the International. | March 31, 2023

Vastra gotalands lanIrina kofflerHowardl weinerGabriele cerroneMattheww davisHoward weinerPaul spencerTiziana life sciences announcesLifesci advisorsBusiness developmentTiziana life sciencesInternational conference on alzheimerTiziana life sciences ltdAnn romney centerInternational conferenceRelated neurological disorders conference

Tiziana Life Sciences Announces IND filed for Phase 2 Study of Milciclib in Combination with Gemcitabine for Non-Small Cell Lung Cancer

Tiziana Life Sciences Announces IND filed for Phase 2 Study of Milciclib in Combination with Gemcitabine for Non-Small Cell Lung CancerNEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing br.

Hana malikGabriele cerroneTiziana life sciencesTiziana life sciences ltdBusiness developmentTiziana life sciences announcesNon small cell lungLife sciencesInvestigational new drugExecutive chairmanChief executive officerInvestor relations

vimarsana © 2020. All Rights Reserved.